What is the prevalence of Sweet Syndrome?

Sweet syndrome, or acute febrile neutrophilic dermatosis, is a rare condition with no precise global prevalence data, though it is estimated to affect fewer than 1 in 2,000 people. While incidence rates are not formally tracked by global registries, the condition is recognized as a rare inflammatory disorder that typically presents in middle-aged adults, though it can occur at any age.

Who is most commonly affected by Sweet syndrome?

Sweet syndrome shows a marked predilection for women, with a female-to-male ratio of approximately 4:1. While Sweet syndrome can affect individuals of any age, the typical age of onset is between 30 and 60 years. Although rare, pediatric cases of Sweet syndrome have been documented in clinical literature, often associated with underlying infections or malignancy.

Is Sweet syndrome considered a rare disease?

Yes, Sweet syndrome is classified as a rare disease. Epidemiological data remains challenging to quantify because the condition is frequently underdiagnosed or misdiagnosed as an infectious process. Because Sweet syndrome can be idiopathic (occurring on its own) or paraneoplastic (associated with cancer), many cases are recorded within the statistics of the underlying primary condition rather than as independent cases of Sweet syndrome.

What factors influence the prevalence of Sweet syndrome?

There are no known specific geographic or ethnic predispositions for Sweet syndrome. However, the reported frequency is often tied to the clinical setting, with higher identification rates in oncology and rheumatology centers. At DiseaseMaps.org, 73 people with Sweet syndrome have joined our community, providing a vital real-world look at the patient experience that often outpaces formal clinical registry data.

Key considerations regarding Sweet syndrome statistics:

• Female predominance: Women are affected significantly more often than men.


• Age of onset: Most patients are diagnosed between their 30s and 60s.


• Diagnostic hurdles: The lack of a single definitive genetic marker leads to significant under-reporting.


• Community insights: DiseaseMaps.org data helps bridge the gap where large-scale epidemiological studies are currently lacking.

Next steps

• Consult a dermatologist or rheumatologist for a formal skin biopsy if you suspect Sweet syndrome.


• Join the DiseaseMaps.org community to connect with others sharing their diagnostic journey.


• Request a screening for underlying hematologic disorders, as these are frequently associated with the condition.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult with a qualified healthcare professional regarding your specific diagnosis.

References

• NIH Genetic and Rare Diseases Information Center (GARD) - Sweet Syndrome profile.


• Orphanet: Portal for rare diseases and orphan drugs (ORPHA:3266).


• PubMed: "Acute Febrile Neutrophilic Dermatosis (Sweet Syndrome)" – Clinical Review.


• NORD (National Organization for Rare Disorders) database.